sweroside has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Choi, Y; Kim, MH; Yang, WM | 1 |
| Cheng, R; Ding, L; Ding, P; Gong, J; Huang, W; Li, J; Shu, F; Sun, H; Tong, R; Wang, Z; Yang, L; Yang, Q | 1 |
| Cho, YY; Han, SH; Jang, JH; Jang, JK; Kang, HC; Kim, SW; Lee, HS; Lee, JY; Ma, KH; Yang, G | 1 |
| Ding, Y; Jiang, H; Meng, B; Xiang, G; Yu, X; Zhu, B | 1 |
| Gong, JT; Tang, XW; Wang, GY; Wang, ZT; Yang, F; Yang, L; Yang, QL | 1 |
6 other study(ies) available for sweroside and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Promotion of osteogenesis by Sweroside via BMP2-involved signaling in postmenopausal osteoporosis.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Differentiation; Disease Models, Animal; Female; Humans; Iridoid Glucosides; Mice; Osteoblasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Seminal Vesicle Secretory Proteins; Signal Transduction | 2021 |
Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
Topics: Animals; CD36 Antigens; Diet, High-Fat; Disease Models, Animal; Fibroblast Growth Factors; Gene Regulatory Networks; HEK293 Cells; Humans; Inflammation Mediators; Insulin Resistance; Iridoid Glucosides; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; PPAR alpha; Transcriptome; Weight Gain | 2020 |
Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
Topics: Animals; Caspase 1; Choline; Diet; Disease Models, Animal; DNA, Mitochondrial; Gene Expression Regulation; Injections, Intraperitoneal; Interleukin-1beta; Iridoid Glucosides; Liver; Macrophages; Methionine; Mice; Mitochondria, Liver; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Treatment Outcome | 2020 |
Sweroside-mediated mTORC1 hyperactivation in bone marrow mesenchymal stem cells promotes osteogenic differentiation.
Topics: Animals; Biomarkers; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Iridoid Glucosides; Mechanistic Target of Rapamycin Complex 1; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Osteocalcin; Osteoporosis, Postmenopausal; Signal Transduction; Sp7 Transcription Factor; X-Ray Microtomography | 2019 |
Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.
Topics: 1-Naphthylisothiocyanate; Animals; Anti-Inflammatory Agents; Bile Acids and Salts; Biomarkers; Cell Survival; Cholestasis; Disease Models, Animal; Gene Expression; Hepatocytes; Immunologic Factors; Iridoid Glucosides; Liver; Male; Mice; Mice, Inbred C57BL; Primary Cell Culture | 2016 |